Mall MA, Wainwright CE, Legg J, Chilvers M, et al. Elexacaftor/tezacaftor/ivacaftor in children aged >/=6 years with cystic fibrosis heterozygous for F508del and a minimal function mutation: results from a 96-week open-label extension study. Eur Respir J 2025;66:2402435.
PMID: 40210412